ARCH Venture Partners XIV, L.P. buys $18M of Aspen Neuroscience, Inc. (ASPE) as a 10% owner
An open-market purchase on Nov 2, reported to the SEC on Nov 2. Information only, not investment advice.
Aspen Neuroscience, Inc. (ASPE) 10% owner ARCH Venture Partners XIV, L.P. purchased about $18 million of stock on Nov 2: 1,200,000 shares at an average of $15.00, according to an SEC filing.
It is an open-market purchase (transaction code P) of common stock, the kind of trade insiders make with their own money. The trade was reported within two business days, as Section 16 requires.
After the trade, the filing lists 1,200,000 shares held.
The numbers below are taken from the Form 4 as filed with the SEC.
| Company | Aspen Neuroscience, Inc. (ASPE) |
|---|---|
| Insider | ARCH Venture Partners XIV, L.P. |
| Role | 10% owner |
| Transaction | Open-market purchase (code P) |
| Shares | 1,200,000 |
| Average price | $15.00 |
| Value | $18,000,000 |
| Trade date | Nov 2, 2026 |
| Filed with the SEC | Nov 2, 2026, 9:46 PM ET |
| Shares held after | 1,200,000 |
| Ownership | Direct |
| Rule 10b5-1 plan | Not marked in the filing |
See this filing row by row in Insider Stock Trader
See all the latest insider trades · Read more ASPE insider trading news
Source: SEC Form 4. Information only, not investment advice. Not affiliated with or endorsed by the U.S. Securities and Exchange Commission.
Related Articles
- Insider Trading News
10% owner ARCH Venture Fund X, L.P. adds $20M of Aspen Neuroscience, Inc. stock
- Insider Trading News
Insider trades of the day, Nov 2: 17 buys and 42 sales over $100,000
- Insider Trading News
10% owner Equinox Partners Investment Management LLC buys $348,694 of Silvercrest Asset Management Group Inc. stock
- Insider Trading News
10% owner Saba Capital Management, L.P. buys $103,285 of Gabelli Healthcare & WellnessRx Trust stock
- Insider Trading News
Wendy Silverstein, a director at TPG RE Finance Trust, Inc., buys $253,239 of stock
